| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |